| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of Immunotherapy Regimens on Primary Renal Tumours: A Systematic Review
|
Jones, James O.
|
|
|
|
4 |
p. 221-236
|
artikel
|
| 2 |
A Shared Decision-Making Model for Management of Small Renal Masses: Optimizing the Patient Experience
|
Caruso, Adele Marie
|
|
|
|
4 |
p. 169-176
|
artikel
|
| 3 |
Clinical Trials Corner
|
Parikh, Mamta
|
|
|
|
4 |
p. 263-264
|
artikel
|
| 4 |
Clinical Trials Corner: Another Approach to Treatment of Advanced Papillary Renal Cell Carcinoma
|
Parikh, Mamta
|
|
|
|
4 |
p. 237-238
|
artikel
|
| 5 |
Clinical Trials Corner: Healthy Competition
|
Parikh, Mamta
|
|
|
|
4 |
p. 211-212
|
artikel
|
| 6 |
Clinical Trials Corner: Reimagining RADICAL
|
Parikh, Mamta
|
|
|
|
4 |
p. 219-220
|
artikel
|
| 7 |
First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials
|
Hahn, Andrew W.
|
|
|
|
4 |
p. 207-217
|
artikel
|
| 8 |
Immune Checkpoint Inhibition, the Key to Success in Renal Cell Carcinoma?
|
Reijm, E.A.
|
|
|
|
4 |
p. 199-211
|
artikel
|
| 9 |
Immune Checkpoint Inhibitors in the Pre-operative Setting and Impact on the Primary Renal Tumor
|
Gulati, Shuchi
|
|
|
|
4 |
p. 201-203
|
artikel
|
| 10 |
Individualised Predictions of the Survival Benefit Due to Adjuvant Therapy in a Randomised Trial of Sorafenib after Nephrectomy for Localised Renal Cell Carcinoma
|
Lawrence, Nicola J.
|
|
|
|
4 |
p. 185-195
|
artikel
|
| 11 |
Individualization of Dose and Schedule Based On Toxicity for Oral VEGF Drugs in Kidney Cancer
|
Parmar, Ambika
|
|
|
|
4 |
p. 213-225
|
artikel
|
| 12 |
Long-Term Outcomes in Clear-Cell Renal Cell Carcinoma Patients Treated with Complete Metastasectomy
|
Verbiest, Annelies
|
|
|
|
4 |
p. 177-183
|
artikel
|
| 13 |
Phase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma1
|
Parikh, Mamta
|
|
|
|
4 |
p. 181-187
|
artikel
|
| 14 |
Predictors of Survival Outcomes in Non-Metastatic Renal Cell Carcinoma in Latin America and Spain: A Multicentric Analysis
|
Zequi, Stênio de Cássio
|
|
|
|
4 |
p. 253-261
|
artikel
|
| 15 |
Prognostic Impact of Lymphnode Metastases in Patients with Metastatic Renal Cell Carcinoma
|
Eggers, Hendrik
|
|
|
|
4 |
p. 199-206
|
artikel
|
| 16 |
Real-World Results from One Year of Therapy with Tivozanib
|
Staehler, Michael
|
|
|
|
4 |
p. 235-239
|
artikel
|
| 17 |
Retrospective Study of Real-World Treatment Patterns and Outcomes in Advanced/Metastatic Renal Cell Carcinoma Patients Receiving Lenvatinib/Everolimus after Heavy Pretreatment1
|
Vogelzang, Nicholas J.
|
|
|
|
4 |
p. 189-197
|
artikel
|
| 18 |
Sarcomatoid Renal Cell Carcinoma: The Present and Future of Treatment Paradigms
|
Candelario, Nellowe
|
|
|
|
4 |
p. 167-179
|
artikel
|
| 19 |
Systematic Review of Comparative Studies of 3D Models for Preoperative Planning in Minimally Invasive Partial Nephrectomy
|
Piramide, Federico
|
|
|
|
4 |
p. 205-219
|
artikel
|
| 20 |
The Trouble with Doublets: Making Sense of Combination Strategies in Advanced Kidney Cancer
|
Lara Jr., Primo N.
|
|
|
|
4 |
p. 167-168
|
artikel
|
| 21 |
The Value of Multiparametric MRI for Assessment of Inferior Vena Cava Wall Invasion by Renal Cell Carcinoma Thrombus: A Prospective Feasibility Study
|
van Oostenbrugge, Tim J.
|
|
|
|
4 |
p. 227-233
|
artikel
|
| 22 |
Tissue Based Biomarkers for Metastatic Clear Cell Renal Carcinoma: A Systematic Review
|
Schmidt, Andrew L.
|
|
|
|
4 |
p. 197-210
|
artikel
|
| 23 |
Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99mTc-MDP Bone Scan in a Prospective Clinical Trial
|
Dibble, Elizabeth H.
|
|
|
|
4 |
p. 241-251
|
artikel
|
Tijdschrift beschrijving